Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial.

@article{Prasad2014IntravenousAB,
  title={Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial.},
  author={Kameshwar Prasad and Alka Sharma and Ajay Garg and Sujata Mohanty and S. O. Bhatnagar and Sharat Johri and Kunwar Karni Singh and Velu Nair and Ravi Shankar Sarkar and Sankar Prasad Gorthi and Kaukab Maqbool Hassan and Sudesh S. Prabhakar and Neelam Marwaha and Niranjan Khandelwal and Usha K Misra and Jayantee Kalita and Soniya Nityanand},
  journal={Stroke},
  year={2014},
  volume={45 12},
  pages={3618-24}
}
BACKGROUND AND PURPOSE Pilot studies have suggested benefit from intravenous administration of bone marrow mononuclear stem cells (BMSCs) in stroke. We explored the efficacy and safety of autologous BMSCs in subacute ischemic stroke. METHODS This was a phase II, multicenter, parallel group, randomized trial with blinded outcome assessment that included 120 patients. Patients with subacute ischemic stroke were randomly assigned to the arm that received intravenous infusion of autologous BMSCs… CONTINUE READING
64 Citations
14 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 64 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 14 references

Estimating sample size and power: applications and examples

  • WS Browner, TB Newman, SB. Hully
  • 2007
1 Excerpt

Similar Papers

Loading similar papers…